Literature DB >> 28730625

FGF9 mutation causes craniosynostosis along with multiple synostoses.

Maria Rodriguez-Zabala1, Miriam Aza-Carmona1,2,3, Carlos I Rivera-Pedroza1,3, Alberta Belinchón1,2,3, Isabel Guerrero-Zapata1, Jimena Barraza-García1,2,3, Elena Vallespin1,2, Min Lu4, Angela Del Pozo1,2, Marc J Glucksman4, Fernando Santos-Simarro1,2,3, Karen E Heath1,2,3.   

Abstract

Craniosynostosis is commonly caused by mutations in fibroblast growth factor receptors (FGFRs), highlighting the essential role of FGF-mediated signaling in skeletal development. We set out to identify the molecular defect in a family referred for craniosynostosis and in whom no mutation was previously detected. Using next-generation sequencing, we identified a novel missense mutation in FGF9. Modeling based upon the crystal structure and functional studies confirmed its pathogenicity showing that it impaired homodimerization and FGFR3 binding. Only one FGF9 mutation has been previously reported in a multigeneration family with multiple synostoses (SYNS3) but no signs of craniosynostosis. In contrast, our family has a greater phenotypic resemblance to that observed in the Fgf9 spontaneous mouse mutant, elbow-knee-synostosis, Eks, with both multiple synostoses and craniosynostosis. We have demonstrated for the first time that mutations in FGF9 cause craniosynostosis in humans and confirm that FGF9 mutations cause multiple synostoses.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  FGF9; bone; craniosynostosis; skeletal dysplasia; suture

Mesh:

Substances:

Year:  2017        PMID: 28730625     DOI: 10.1002/humu.23292

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  4 in total

Review 1.  Fibroblast growth factor signalling in osteoarthritis and cartilage repair.

Authors:  Yangli Xie; Allen Zinkle; Lin Chen; Moosa Mohammadi
Journal:  Nat Rev Rheumatol       Date:  2020-08-17       Impact factor: 20.543

2.  Osteocyte Death and Bone Overgrowth in Mice Lacking Fibroblast Growth Factor Receptors 1 and 2 in Mature Osteoblasts and Osteocytes.

Authors:  Jennifer McKenzie; Craig Smith; Kannan Karuppaiah; Joshua Langberg; Matthew J Silva; David M Ornitz
Journal:  J Bone Miner Res       Date:  2019-06-17       Impact factor: 6.741

Review 3.  FGF/FGFR signaling in health and disease.

Authors:  Yangli Xie; Nan Su; Jing Yang; Qiaoyan Tan; Shuo Huang; Min Jin; Zhenhong Ni; Bin Zhang; Dali Zhang; Fengtao Luo; Hangang Chen; Xianding Sun; Jian Q Feng; Huabing Qi; Lin Chen
Journal:  Signal Transduct Target Ther       Date:  2020-09-02

4.  A novel heterozygous variant in FGF9 associated with previously unreported features of multiple synostosis syndrome 3.

Authors:  Ann-Charlotte Thuresson; Brittany Croft; Yasmin D Hailer; Gunnar Liminga; Carl-Göran Arvidsson; Vincent R Harley; Eva-Lena Stattin
Journal:  Clin Genet       Date:  2021-02       Impact factor: 4.438

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.